CU, B., SD, C., X, L., P, S., X, Z., C, D., . . . E, L. (2017). Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers. Cancer discovery, 7(9), 1030. https://doi.org/10.1158/2159-8290.CD-16-1414
Chicago Style (17th ed.) CitationCU, Bialucha, et al. "Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers." Cancer Discovery 7, no. 9 (2017): 1030. https://doi.org/10.1158/2159-8290.CD-16-1414.
MLA (9th ed.) CitationCU, Bialucha, et al. "Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers." Cancer Discovery, vol. 7, no. 9, 2017, p. 1030, https://doi.org/10.1158/2159-8290.CD-16-1414.